MedTrace Logo

Kefir Peptides for Bone Fracture Healing

NCT07166458 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-03-24

No results posted yet for this study

Summary

This study is designed to evaluate the effects of kefir-derived peptides on bone healing in patients with upper limb fractures. Kefir peptides are natural protein fragments that may promote bone formation and reduce inflammation. Participants with recent upper limb fractures will be randomly assigned to receive either kefir peptide supplementation or standard treatment. The main purpose of this study is to determine whether kefir peptides can accelerate bone healing and improve recovery compared to standard care.

Conditions

  • Bone Fractures

Interventions

DIETARY_SUPPLEMENT

Kefir Peptide

Oral supplementation with kefir-derived bioactive peptides given daily in addition to standard care.

OTHER

Standard Care (in control arm)

Standard fracture management including immobilization, pain control, and routine follow-up care.

Sponsors & Collaborators

  • Jen-Chieh Lai

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-13
Primary Completion
2024-07-20
Completion
2025-04-20

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07166458 on ClinicalTrials.gov